Determinants of COVID-19 cases and deaths in OECD countries

Basit Öğe Kaydı
dc.authoridTekerek, Burak/0000-0001-7617-2368
dc.authoridGUNALTAY, Meliha Melis/0000-0002-2883-4416
dc.authoridTURGUT, MERYEM/0000-0001-9320-3250
dc.contributor.authorTekerek, Burak
dc.contributor.authorGunaltay, Meliha Melis
dc.contributor.authorOzler, Gokcen
dc.contributor.authorTurgut, Meryem
dc.date.accessioned2024-11-07T13:32:57Z
dc.date.available2024-11-07T13:32:57Z
dc.date.issued2024
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractAimThis research aims to examine the effects of variables that can affect COVID-19 deaths and cases in Organisation for Economic Co-operation and Development (OECD) countries during the years 2020 (first wave), 2021 (vaccine available), and 2022 (vaccine available and Omicron variant appeared).Material and methodThe factors that are thought to affect the case and death rates in 37 OECD countries were examined by multiple linear regression analysis using SPSS 22. The dependent variables were the COVID-19 deaths and cases per 10,000 (in 2020, 2021, and 2022); the independent variables were universal health coverage, physicians, nurses, intensive care beds, hospital beds, non-communicable diseases mortality per 100,000 people, population over 65 years of age, out-of-pocket expenditure, private expenditure, and health expenditure per capita and percent of % GDP.ResultsIt was determined that the non-communicable diseases mortality is the relatively important variable COVID-19 cases and deaths in 2020 and 2021. After controlling for the scores of other variables, according to the ss coefficients, a one-unit increase in the number of physicians variable increases COVID-19 cases by 1.14 units in 2022; a one-unit increase in the universal coverage variable decreases COVID-19 deaths by 0.33 units in 2022.ConclusionThe results of this research provide evidence that the effects of the COVID-19 outbreak have changed between 2020, the first wave of the epidemic, 2021, when the vaccine is available, and 2022, when both the vaccine is available and the Omicron variant is seen. With the increase in vaccination in 2022, the impact of non-communicable diseases mortality on the number of COVID-19 cases has decreased.
dc.identifier.doi10.1007/s10389-023-01820-9
dc.identifier.endpage484
dc.identifier.issn2198-1833
dc.identifier.issn1613-2238
dc.identifier.issue3
dc.identifier.pmid36721741
dc.identifier.scopus2-s2.0-85146829182
dc.identifier.scopusqualityN/A
dc.identifier.startpage473
dc.identifier.urihttps://doi.org/10.1007/s10389-023-01820-9
dc.identifier.urihttps://hdl.handle.net/11480/15703
dc.identifier.volume32
dc.identifier.wosWOS:000920839000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer Heidelberg
dc.relation.ispartofJournal of Public Health-Heidelberg
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectCOVID-19
dc.subjectHealth resources
dc.subjectHealth expenditures
dc.subjectNoncommunicable diseases
dc.titleDeterminants of COVID-19 cases and deaths in OECD countries
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu